EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H19N5O4 |
| Net Charge | 0 |
| Average Mass | 393.403 |
| Monoisotopic Mass | 393.14370 |
| SMILES | Cc1cc(C)c(N2C(=O)NC(=O)C(=CNNC(=O)c3ccncc3)C2=O)c(C)c1 |
| InChI | InChI=1S/C20H19N5O4/c1-11-8-12(2)16(13(3)9-11)25-19(28)15(18(27)23-20(25)29)10-22-24-17(26)14-4-6-21-7-5-14/h4-10,22H,1-3H3,(H,24,26)(H,23,27,29) |
| InChIKey | VRMVSHOHANAVAR-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N'-[[2,4,6-trioxo-1-(2,4,6-trimethylphenyl)-1,3-diazinan-5-ylidene]methyl]-4-pyridinecarbohydrazide (CHEBI:108474) is a barbiturates (CHEBI:22693) |
| Manual Xrefs | Databases |
|---|---|
| LSM-19850 | LINCS |